Results 311 to 320 of about 12,483,860 (378)
Some of the next articles are maybe not open access.

Tumor-Associated Antigens

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation, 2013
Targeting tumor-associated antigens (TAAs) is a promising approach for cancer immunotherapy. One of the main advantages of targeting TAAs is that it can minimize the off-target toxicities of conventional systemic cancer therapies, to include ...
G. Alatrash   +2 more
semanticscholar   +2 more sources

Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer

open access: yesTumor Biology, 2015
We aimed to evaluate the immunodiagnostic values of autoantibodies to a panel of six tumor-associated antigens (TAAs) in the detection of patients with breast cancer. This study determines whether a panel of multiple TAAs would enhance antibody detection
Weihong Liu   +7 more
semanticscholar   +2 more sources

Direct Presentation of Tumor‐Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell‐Mimicking Nanovaccines

Advances in Materials, 2022
Dendritic cells (DCs)‐based vaccines are an approved method for inducing potent antigen‐specific immune responses to eliminate tumor cells. However, this promising strategy still faces challenges such as tumor‐associated antigens (TAAs) loading, lymph ...
J. Zhang   +6 more
semanticscholar   +1 more source

Autoantibodies to tumor-associated antigens in lung cancer diagnosis.

Advances in Clinical Chemistry, 2021
Lung cancer (LC) accounts for the majority of cancer-related deaths worldwide. Although screening the high-risk population by low-dose CT (LDCT) has reduced mortality, the cost and high false positivity rate has prevented its general diagnostic use.
Xiu-Zhi Zhang   +4 more
semanticscholar   +1 more source

Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies

Hepatology, 2020
There are few treatment options for advanced-stage hepatocellular carcinoma (HCC). Targeting tumor-associated antigens (TAAs) for HCC immunotherapy has been tested clinically for many years with limited success.
Li-Gong Lu   +12 more
semanticscholar   +1 more source

Effect of Gold on Tumor-associated Antigens

Cancer Biotherapy and Radiopharmaceuticals, 1999
A gold compound, which is an anti-rheumatoid agent, was clinically applied to patients showing a high level of tumor-associated antigens. Two patients showed no clear evidence of recurrence except for a high level of tumor-associated antigens. The gold compound was injected i.m.
H, Kamei   +4 more
openaire   +2 more sources

Cytostructural Localization of a Tumor-Associated Antigen

Science, 1980
Tumor cell membrane glycoproteins may be involved in the induction of tumor immunity or in the escape of tumors from immunologic defense mechanisms. Forty-four benign and malignant breast lesions were examined for the presence of a carbohydrate precursor antigen (T antigen) of the human blood group system MN.
D R, Howard, J G, Batsakis
openaire   +2 more sources

Studies on tumor-associated antigen: TAA

Journal of Surgical Research, 1973
Abstract A method for the preparation of tumor-associated antigen (TAA) is described. We have been able to demonstrate two antigens with common antigenic determinants that are separable by ion-exchange chromatography and electrophoresis. These antigens appear identical by Ouchterlony immuno-diffusion analysis and by Sephadex chromatography.
P L, Gerfo   +3 more
openaire   +2 more sources

Synthesis of Tumor-Associated Glycopeptide Antigens

Bioorganic & Medicinal Chemistry, 2002
Carbohydrates and peptides linked together in glycoproteins constitute important components of the molecular communication between cells in multicellular organisms. Cell morphogenesis and tumorigenesis are accompanied by changes in the glycoprotein profiles of the outer cell membranes.
Constanze, Brocke, Horst, Kunz
openaire   +2 more sources

Natural Antibodies to Tumor-Associated Antigens

2016
Natural autoantibodies raised by humoral immune response to cancer can be exploited to identify potential tumor-associated antigens (TAAs), and might constitute new putative prognostic and/or diagnostic biomarkers. Here we describe how sera from tumor patients can be used to identify TAAs by screening antibody immunoreactivity against the cancer ...
Sheila María, Álvarez-Fernández   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy